Understanding Normal vs Optimal Lab Ranges: Why "Normal" Isn't Always Good Enough
Normal vs Optimal Lab Ranges
"Your labs are normal" doesn't always mean you're healthy. There's a crucial difference between reference ranges and optimal ranges.
What Are Reference Ranges?
Reference ranges are statistical calculations based on the general population—typically the middle 95% of test results. Here's the problem: the "general population" includes many unhealthy people.
The Optimal Range Difference
Optimal ranges represent the values associated with the best health outcomes, not just the absence of disease.
Example: Fasting Glucose - Reference Range: 70-99 mg/dL (considered "normal") - Optimal Range: 70-85 mg/dL - Why it matters: Values in the 90s may indicate prediabetic changes
Example: Vitamin D - Reference Range: 30-100 ng/mL - Optimal Range: 50-80 ng/mL - Why it matters: Below 50 associated with increased disease risk
Example: Ferritin - Reference Range (Women): 12-150 ng/mL - Optimal Range: 50-100 ng/mL - Why it matters: Low-normal still causes fatigue symptoms
Key Differences by Biomarker
| Biomarker | Normal Range | Optimal Range |
|---|---|---|
| TSH | 0.5-4.5 mIU/L | 1.0-2.0 mIU/L |
| HbA1c | <5.7% | <5.3% |
| LDL | <100 mg/dL | <70 mg/dL |
| HDL | >40 mg/dL | >60 mg/dL |
| CRP | <3.0 mg/L | <1.0 mg/L |
The Functional Medicine Approach
Functional medicine practitioners focus on optimal ranges because they:
1. Identify problems earlier 2. Enable preventive interventions 3. Optimize performance, not just prevent disease 4. Recognize individual variation
How Elabus Uses Optimal Ranges
Our AI evaluates your results against both reference and optimal ranges, flagging markers that are "normal but not optimal."
Turn this article into a better next appointment
Reading is useful. Bringing a clearer story is better. E-Labus helps patients organize the actual report, understand what changed, and walk in with sharper questions than generic AI summaries can give.
Prefer to keep learning first? Visit the patient results hub.
